Idiopathic Orbital Inflammation Underlying Drug-Associated Thyroid Eye Disease

Authors

  • Hythem Abouodah The University of Kansas School of Medicine
  • Stephen L. Ambrose, M.D. University of Kansas Eye Center
  • Jordan E. Miller, M.D. University of Kansas Eye Center
  • Mary K. Mitchell University of Kansas School of Medicine
  • Jason A. Sokol, M.D. University of Kansas Eye Center Oculofacial Plastic and Orbital Surgery

DOI:

https://doi.org/10.17161/kjm.vol15.18210

Keywords:

Alemtuzumab, Thyroid, Graves', lymphoma, inflammatory

Downloads

Published

2022-10-24

How to Cite

Abouodah, H., Ambrose, S. L., Miller, J. E., Mitchell, M. K., & Sokol, J. A. (2022). Idiopathic Orbital Inflammation Underlying Drug-Associated Thyroid Eye Disease. Kansas Journal of Medicine, 15(3), 380–381. https://doi.org/10.17161/kjm.vol15.18210

Issue

Section

Case Reports